×
Program Committee
-
Toshihiko Doi, MD, PhD Deputy Director / Chief, Experimental Therapeutics
National Cancer Center Hospital East, Japan -
Noboru Yamamoto, MD, PhD Deputy Director, Department of Experimental Therapeutics
National Cancer Center Hospital, Japan -
Masakazu Hirata, MD, PhD Clinical Reviewer, Division of RS Consultation, Kansai Branch
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Toshiko Ishibashi, PhD, RN Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan -
Eri Sekine Executive Vice President Data Business
CMIC Co., Ltd, Japan -
Takuya Suzuki Associate Director, Japan anad Asia Clinical Development Department
Eisai Co., Ltd., Japan -
Tomoko Takami Director, Oncology Clinical Development, Oncology Science Unit
MSD K.K., Japan -
Atsushi Tsukamoto, PhD, MSc Head is Therapeutic Area Strategies
Daiichi Sankyo, United States -
Hironobu Saito, PhD Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan -
Junko Sato, PhD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Have an account?